世界の新型コロナウイルス感染症診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Covid-19 Diagnostic Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1617 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、151ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、新型コロナウイルス感染症診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（イムノアッセイ、ゲノム・WGSロール、rRT-PCR）、用途別市場規模（病院、研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・新型コロナウイルス感染症診断の市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症診断の種類別市場規模（イムノアッセイ、ゲノム・WGSロール、rRT-PCR） ・新型コロナウイルス感染症診断の用途別市場規模（病院、研究所） ・新型コロナウイルス感染症診断の北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Diagnostics、Accelerate Diagnostics、Ador Diagnostics、Akkoni Biosystems、Alveo Technologies、Applied BioCode、Aus Diagnostics、BD Diagnostics、Biocartis、BioFire Diagnostics、bioMérieux、Bio-Rad Laboratories、Bosch Healthcare Solutions GmbH、Cepheid、Co-Diagnostics、Cue Health、Curetis、Diagenode Diagnostics、Diascopic、Diasorin、Expedeon、Fusion Genomics.、GenePOC Diagnostics、GenMark Dx、Hologic、Immunexpress、Inflammatix、Invetech、Janssen Diagnostics） ・結論

Market Analysis and Insights: Global Covid-19 Diagnostic Market
The global Covid-19 Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Diagnostic market.

Global Covid-19 Diagnostic Scope and Market Size
Covid-19 Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Covid-19 Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunoassay
Genomic and WGS Role
rRT-PCR

Segment by Application
Hospital
Laboratory

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Diagnostics
Accelerate Diagnostics
Ador Diagnostics
Akkoni Biosystems
Alveo Technologies
Applied BioCode
Aus Diagnostics
BD Diagnostics
Biocartis
BioFire Diagnostics
bioMérieux
Bio-Rad Laboratories
Bosch Healthcare Solutions GmbH
Cepheid
Co-Diagnostics
Cue Health
Curetis
Diagenode Diagnostics
Diascopic
Diasorin
Expedeon
Fusion Genomics.
GenePOC Diagnostics
GenMark Dx
Hologic
Immunexpress
Inflammatix

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunoassay
1.2.3 Genomic and WGS Role
1.2.4 rRT-PCR
1.3 Market by Application
1.3.1 Global Covid-19 Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Laboratory
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Covid-19 Diagnostic Market Perspective (2016-2027)
2.2 Covid-19 Diagnostic Growth Trends by Regions
2.2.1 Covid-19 Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Covid-19 Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Covid-19 Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Covid-19 Diagnostic Industry Dynamic
2.3.1 Covid-19 Diagnostic Market Trends
2.3.2 Covid-19 Diagnostic Market Drivers
2.3.3 Covid-19 Diagnostic Market Challenges
2.3.4 Covid-19 Diagnostic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Diagnostic Players by Revenue
3.1.1 Global Top Covid-19 Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Covid-19 Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Covid-19 Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Diagnostic Revenue
3.4 Global Covid-19 Diagnostic Market Concentration Ratio
3.4.1 Global Covid-19 Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Diagnostic Revenue in 2020
3.5 Covid-19 Diagnostic Key Players Head office and Area Served
3.6 Key Players Covid-19 Diagnostic Product Solution and Service
3.7 Date of Enter into Covid-19 Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Diagnostic Breakdown Data by Type
4.1 Global Covid-19 Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Covid-19 Diagnostic Forecasted Market Size by Type (2022-2027)

5 Covid-19 Diagnostic Breakdown Data by Application
5.1 Global Covid-19 Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Covid-19 Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Covid-19 Diagnostic Market Size (2016-2027)
6.2 North America Covid-19 Diagnostic Market Size by Type
6.2.1 North America Covid-19 Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Covid-19 Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Covid-19 Diagnostic Market Size by Type (2016-2027)
6.3 North America Covid-19 Diagnostic Market Size by Application
6.3.1 North America Covid-19 Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Covid-19 Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Covid-19 Diagnostic Market Size by Application (2016-2027)
6.4 North America Covid-19 Diagnostic Market Size by Country
6.4.1 North America Covid-19 Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Covid-19 Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Covid-19 Diagnostic Market Size (2016-2027)
7.2 Europe Covid-19 Diagnostic Market Size by Type
7.2.1 Europe Covid-19 Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Covid-19 Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Covid-19 Diagnostic Market Size by Type (2016-2027)
7.3 Europe Covid-19 Diagnostic Market Size by Application
7.3.1 Europe Covid-19 Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Covid-19 Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Covid-19 Diagnostic Market Size by Application (2016-2027)
7.4 Europe Covid-19 Diagnostic Market Size by Country
7.4.1 Europe Covid-19 Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Covid-19 Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Covid-19 Diagnostic Market Size by Type
8.2.1 Asia-Pacific Covid-19 Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Covid-19 Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Covid-19 Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Covid-19 Diagnostic Market Size by Application
8.3.1 Asia-Pacific Covid-19 Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Covid-19 Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Covid-19 Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Covid-19 Diagnostic Market Size by Region
8.4.1 Asia-Pacific Covid-19 Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Covid-19 Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Covid-19 Diagnostic Market Size (2016-2027)
9.2 Latin America Covid-19 Diagnostic Market Size by Type
9.2.1 Latin America Covid-19 Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Covid-19 Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Covid-19 Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Covid-19 Diagnostic Market Size by Application
9.3.1 Latin America Covid-19 Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Covid-19 Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Covid-19 Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Covid-19 Diagnostic Market Size by Country
9.4.1 Latin America Covid-19 Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Covid-19 Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Covid-19 Diagnostic Market Size by Type
10.2.1 Middle East & Africa Covid-19 Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Covid-19 Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Covid-19 Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Covid-19 Diagnostic Market Size by Application
10.3.1 Middle East & Africa Covid-19 Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Covid-19 Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Covid-19 Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Covid-19 Diagnostic Market Size by Country
10.4.1 Middle East & Africa Covid-19 Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Covid-19 Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Covid-19 Diagnostic Introduction
11.1.4 Abbott Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.1.5 Abbott Diagnostics Recent Development
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Details
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Covid-19 Diagnostic Introduction
11.2.4 Accelerate Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.2.5 Accelerate Diagnostics Recent Development
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Details
11.3.2 Ador Diagnostics Business Overview
11.3.3 Ador Diagnostics Covid-19 Diagnostic Introduction
11.3.4 Ador Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.3.5 Ador Diagnostics Recent Development
11.4 Akkoni Biosystems
11.4.1 Akkoni Biosystems Company Details
11.4.2 Akkoni Biosystems Business Overview
11.4.3 Akkoni Biosystems Covid-19 Diagnostic Introduction
11.4.4 Akkoni Biosystems Revenue in Covid-19 Diagnostic Business (2016-2021)
11.4.5 Akkoni Biosystems Recent Development
11.5 Alveo Technologies
11.5.1 Alveo Technologies Company Details
11.5.2 Alveo Technologies Business Overview
11.5.3 Alveo Technologies Covid-19 Diagnostic Introduction
11.5.4 Alveo Technologies Revenue in Covid-19 Diagnostic Business (2016-2021)
11.5.5 Alveo Technologies Recent Development
11.6 Applied BioCode
11.6.1 Applied BioCode Company Details
11.6.2 Applied BioCode Business Overview
11.6.3 Applied BioCode Covid-19 Diagnostic Introduction
11.6.4 Applied BioCode Revenue in Covid-19 Diagnostic Business (2016-2021)
11.6.5 Applied BioCode Recent Development
11.7 Aus Diagnostics
11.7.1 Aus Diagnostics Company Details
11.7.2 Aus Diagnostics Business Overview
11.7.3 Aus Diagnostics Covid-19 Diagnostic Introduction
11.7.4 Aus Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.7.5 Aus Diagnostics Recent Development
11.8 BD Diagnostics
11.8.1 BD Diagnostics Company Details
11.8.2 BD Diagnostics Business Overview
11.8.3 BD Diagnostics Covid-19 Diagnostic Introduction
11.8.4 BD Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.8.5 BD Diagnostics Recent Development
11.9 Biocartis
11.9.1 Biocartis Company Details
11.9.2 Biocartis Business Overview
11.9.3 Biocartis Covid-19 Diagnostic Introduction
11.9.4 Biocartis Revenue in Covid-19 Diagnostic Business (2016-2021)
11.9.5 Biocartis Recent Development
11.10 BioFire Diagnostics
11.10.1 BioFire Diagnostics Company Details
11.10.2 BioFire Diagnostics Business Overview
11.10.3 BioFire Diagnostics Covid-19 Diagnostic Introduction
11.10.4 BioFire Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.10.5 BioFire Diagnostics Recent Development
11.11 bioMérieux
11.11.1 bioMérieux Company Details
11.11.2 bioMérieux Business Overview
11.11.3 bioMérieux Covid-19 Diagnostic Introduction
11.11.4 bioMérieux Revenue in Covid-19 Diagnostic Business (2016-2021)
11.11.5 bioMérieux Recent Development
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Details
11.12.2 Bio-Rad Laboratories Business Overview
11.12.3 Bio-Rad Laboratories Covid-19 Diagnostic Introduction
11.12.4 Bio-Rad Laboratories Revenue in Covid-19 Diagnostic Business (2016-2021)
11.12.5 Bio-Rad Laboratories Recent Development
11.13 Bosch Healthcare Solutions GmbH
11.13.1 Bosch Healthcare Solutions GmbH Company Details
11.13.2 Bosch Healthcare Solutions GmbH Business Overview
11.13.3 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Introduction
11.13.4 Bosch Healthcare Solutions GmbH Revenue in Covid-19 Diagnostic Business (2016-2021)
11.13.5 Bosch Healthcare Solutions GmbH Recent Development
11.14 Cepheid
11.14.1 Cepheid Company Details
11.14.2 Cepheid Business Overview
11.14.3 Cepheid Covid-19 Diagnostic Introduction
11.14.4 Cepheid Revenue in Covid-19 Diagnostic Business (2016-2021)
11.14.5 Cepheid Recent Development
11.15 Co-Diagnostics
11.15.1 Co-Diagnostics Company Details
11.15.2 Co-Diagnostics Business Overview
11.15.3 Co-Diagnostics Covid-19 Diagnostic Introduction
11.15.4 Co-Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.15.5 Co-Diagnostics Recent Development
11.16 Cue Health
11.16.1 Cue Health Company Details
11.16.2 Cue Health Business Overview
11.16.3 Cue Health Covid-19 Diagnostic Introduction
11.16.4 Cue Health Revenue in Covid-19 Diagnostic Business (2016-2021)
11.16.5 Cue Health Recent Development
11.17 Curetis
11.17.1 Curetis Company Details
11.17.2 Curetis Business Overview
11.17.3 Curetis Covid-19 Diagnostic Introduction
11.17.4 Curetis Revenue in Covid-19 Diagnostic Business (2016-2021)
11.17.5 Curetis Recent Development
11.18 Diagenode Diagnostics
11.18.1 Diagenode Diagnostics Company Details
11.18.2 Diagenode Diagnostics Business Overview
11.18.3 Diagenode Diagnostics Covid-19 Diagnostic Introduction
11.18.4 Diagenode Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.18.5 Diagenode Diagnostics Recent Development
11.18 Diascopic
11.25.1 Diascopic Company Details
11.25.2 Diascopic Business Overview
11.25.3 Diascopic Covid-19 Diagnostic Introduction
11.25.4 Diascopic Revenue in Covid-19 Diagnostic Business (2016-2021)
11.25.5 Diascopic Recent Development
11.20 Diasorin
11.20.1 Diasorin Company Details
11.20.2 Diasorin Business Overview
11.20.3 Diasorin Covid-19 Diagnostic Introduction
11.20.4 Diasorin Revenue in Covid-19 Diagnostic Business (2016-2021)
11.20.5 Diasorin Recent Development
11.21 Expedeon
11.21.1 Expedeon Company Details
11.21.2 Expedeon Business Overview
11.21.3 Expedeon Covid-19 Diagnostic Introduction
11.21.4 Expedeon Revenue in Covid-19 Diagnostic Business (2016-2021)
11.21.5 Expedeon Recent Development
11.22 Fusion Genomics.
11.22.1 Fusion Genomics. Company Details
11.22.2 Fusion Genomics. Business Overview
11.22.3 Fusion Genomics. Covid-19 Diagnostic Introduction
11.22.4 Fusion Genomics. Revenue in Covid-19 Diagnostic Business (2016-2021)
11.22.5 Fusion Genomics. Recent Development
11.23 GenePOC Diagnostics
11.23.1 GenePOC Diagnostics Company Details
11.23.2 GenePOC Diagnostics Business Overview
11.23.3 GenePOC Diagnostics Covid-19 Diagnostic Introduction
11.23.4 GenePOC Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.23.5 GenePOC Diagnostics Recent Development
11.24 GenMark Dx
11.24.1 GenMark Dx Company Details
11.24.2 GenMark Dx Business Overview
11.24.3 GenMark Dx Covid-19 Diagnostic Introduction
11.24.4 GenMark Dx Revenue in Covid-19 Diagnostic Business (2016-2021)
11.24.5 GenMark Dx Recent Development
11.25 Hologic
11.25.1 Hologic Company Details
11.25.2 Hologic Business Overview
11.25.3 Hologic Covid-19 Diagnostic Introduction
11.25.4 Hologic Revenue in Covid-19 Diagnostic Business (2016-2021)
11.25.5 Hologic Recent Development
11.26 Immunexpress
11.26.1 Immunexpress Company Details
11.26.2 Immunexpress Business Overview
11.26.3 Immunexpress Covid-19 Diagnostic Introduction
11.26.4 Immunexpress Revenue in Covid-19 Diagnostic Business (2016-2021)
11.26.5 Immunexpress Recent Development
11.27 Inflammatix
11.27.1 Inflammatix Company Details
11.27.2 Inflammatix Business Overview
11.27.3 Inflammatix Covid-19 Diagnostic Introduction
11.27.4 Inflammatix Revenue in Covid-19 Diagnostic Business (2016-2021)
11.27.5 Inflammatix Recent Development
11.28 Invetech
11.28.1 Invetech Company Details
11.28.2 Invetech Business Overview
11.28.3 Invetech Covid-19 Diagnostic Introduction
11.28.4 Invetech Revenue in Covid-19 Diagnostic Business (2016-2021)
11.28.5 Invetech Recent Development
11.29 Janssen Diagnostics
11.29.1 Janssen Diagnostics Company Details
11.29.2 Janssen Diagnostics Business Overview
11.29.3 Janssen Diagnostics Covid-19 Diagnostic Introduction
11.29.4 Janssen Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021)
11.29.5 Janssen Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Covid-19 Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunoassay
Table 3. Key Players of Genomic and WGS Role
Table 4. Key Players of rRT-PCR
Table 5. Global Covid-19 Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Covid-19 Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Covid-19 Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Covid-19 Diagnostic Market Share by Regions (2016-2021)
Table 9. Global Covid-19 Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Covid-19 Diagnostic Market Share by Regions (2022-2027)
Table 11. Covid-19 Diagnostic Market Trends
Table 12. Covid-19 Diagnostic Market Drivers
Table 13. Covid-19 Diagnostic Market Challenges
Table 14. Covid-19 Diagnostic Market Restraints
Table 15. Global Covid-19 Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Covid-19 Diagnostic Market Share by Players (2016-2021)
Table 17. Global Top Covid-19 Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Diagnostic as of 2020)
Table 18. Ranking of Global Top Covid-19 Diagnostic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Covid-19 Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Covid-19 Diagnostic Product Solution and Service
Table 22. Date of Enter into Covid-19 Diagnostic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Covid-19 Diagnostic Revenue Market Share by Type (2016-2021)
Table 26. Global Covid-19 Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Covid-19 Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Covid-19 Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Covid-19 Diagnostic Revenue Market Share by Application (2016-2021)
Table 30. Global Covid-19 Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Covid-19 Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Covid-19 Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Covid-19 Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Covid-19 Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Covid-19 Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Covid-19 Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Covid-19 Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Covid-19 Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Covid-19 Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Covid-19 Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Covid-19 Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Covid-19 Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Covid-19 Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Covid-19 Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Covid-19 Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Covid-19 Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Covid-19 Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Covid-19 Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Covid-19 Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Covid-19 Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Covid-19 Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Covid-19 Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Covid-19 Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Covid-19 Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Covid-19 Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Covid-19 Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Covid-19 Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Diagnostics Company Details
Table 63. Abbott Diagnostics Business Overview
Table 64. Abbott Diagnostics Covid-19 Diagnostic Product
Table 65. Abbott Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 66. Abbott Diagnostics Recent Development
Table 67. Accelerate Diagnostics Company Details
Table 68. Accelerate Diagnostics Business Overview
Table 69. Accelerate Diagnostics Covid-19 Diagnostic Product
Table 70. Accelerate Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 71. Accelerate Diagnostics Recent Development
Table 72. Ador Diagnostics Company Details
Table 73. Ador Diagnostics Business Overview
Table 74. Ador Diagnostics Covid-19 Diagnostic Product
Table 75. Ador Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 76. Ador Diagnostics Recent Development
Table 77. Akkoni Biosystems Company Details
Table 78. Akkoni Biosystems Business Overview
Table 79. Akkoni Biosystems Covid-19 Diagnostic Product
Table 80. Akkoni Biosystems Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 81. Akkoni Biosystems Recent Development
Table 82. Alveo Technologies Company Details
Table 83. Alveo Technologies Business Overview
Table 84. Alveo Technologies Covid-19 Diagnostic Product
Table 85. Alveo Technologies Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 86. Alveo Technologies Recent Development
Table 87. Applied BioCode Company Details
Table 88. Applied BioCode Business Overview
Table 89. Applied BioCode Covid-19 Diagnostic Product
Table 90. Applied BioCode Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 91. Applied BioCode Recent Development
Table 92. Aus Diagnostics Company Details
Table 93. Aus Diagnostics Business Overview
Table 94. Aus Diagnostics Covid-19 Diagnostic Product
Table 95. Aus Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 96. Aus Diagnostics Recent Development
Table 97. BD Diagnostics Company Details
Table 98. BD Diagnostics Business Overview
Table 99. BD Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 100. BD Diagnostics Recent Development
Table 101. Biocartis Company Details
Table 102. Biocartis Business Overview
Table 103. Biocartis Covid-19 Diagnostic Product
Table 104. Biocartis Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 105. Biocartis Recent Development
Table 106. BioFire Diagnostics Company Details
Table 107. BioFire Diagnostics Business Overview
Table 108. BioFire Diagnostics Covid-19 Diagnostic Product
Table 109. BioFire Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 110. BioFire Diagnostics Recent Development
Table 111. bioMérieux Company Details
Table 112. bioMérieux Business Overview
Table 113. bioMérieux Covid-19 Diagnostic Product
Table 114. bioMérieux Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 115. bioMérieux Recent Development
Table 116. Bio-Rad Laboratories Company Details
Table 117. Bio-Rad Laboratories Business Overview
Table 118. Bio-Rad Laboratories Covid-19 Diagnostic Product
Table 119. Bio-Rad Laboratories Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 120. Bio-Rad Laboratories Recent Development
Table 121. Bosch Healthcare Solutions GmbH Company Details
Table 122. Bosch Healthcare Solutions GmbH Business Overview
Table 123. Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Product
Table 124. Bosch Healthcare Solutions GmbH Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 125. Bosch Healthcare Solutions GmbH Recent Development
Table 126. Cepheid Company Details
Table 127. Cepheid Business Overview
Table 128. Cepheid Covid-19 Diagnostic Product
Table 129. Cepheid Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 130. Cepheid Recent Development
Table 131. Co-Diagnostics Company Details
Table 132. Co-Diagnostics Business Overview
Table 133. Co-Diagnostics Covid-19 Diagnostic Product
Table 134. Co-Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 135. Co-Diagnostics Recent Development
Table 136. Cue Health Company Details
Table 137. Cue Health Business Overview
Table 138. Cue Health Covid-19 Diagnostic Product
Table 139. Cue Health Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 140. Cue Health Recent Development
Table 141. Curetis Company Details
Table 142. Curetis Business Overview
Table 143. Curetis Covid-19 Diagnostic Product
Table 144. Curetis Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 145. Curetis Recent Development
Table 146. Diagenode Diagnostics Company Details
Table 147. Diagenode Diagnostics Business Overview
Table 148. Diagenode Diagnostics Covid-19 Diagnostic Product
Table 149. Diagenode Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 150. Diagenode Diagnostics Recent Development
Table 151. Diascopic Company Details
Table 152. Diascopic Business Overview
Table 153. Diascopic Covid-19 Diagnostic Product
Table 154. Diascopic Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 155. Diascopic Recent Development
Table 156. Diasorin Company Details
Table 157. Diasorin Business Overview
Table 158. Diasorin Covid-19 Diagnostic Product
Table 159. Diasorin Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 160. Diasorin Recent Development
Table 161. Expedeon Company Details
Table 162. Expedeon Business Overview
Table 163. Expedeon Covid-19 Diagnostic Product
Table 164. Expedeon Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 165. Expedeon Recent Development
Table 166. Fusion Genomics. Company Details
Table 167. Fusion Genomics. Business Overview
Table 168. Fusion Genomics. Covid-19 Diagnostic Product
Table 169. Fusion Genomics. Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 170. Fusion Genomics. Recent Development
Table 171. GenePOC Diagnostics Company Details
Table 172. GenePOC Diagnostics Business Overview
Table 173. GenePOC Diagnostics Covid-19 Diagnostic Product
Table 174. GenePOC Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 175. GenePOC Diagnostics Recent Development
Table 176. GenMark Dx Company Details
Table 177. GenMark Dx Business Overview
Table 178. GenMark Dx Covid-19 DiagnosticProduct
Table 179. GenMark Dx Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 180. GenMark Dx Recent Development
Table 181. Hologic Company Details
Table 182. Hologic Business Overview
Table 183. Hologic Covid-19 Diagnostic Product
Table 184. Hologic Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 185. Hologic Recent Development
Table 186. Immunexpress Company Details
Table 187. Immunexpress Business Overview
Table 188. Immunexpress Covid-19 Diagnostic Product
Table 189. Immunexpress Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 190. Immunexpress Recent Development
Table 191. Inflammatix Company Details
Table 192. Inflammatix Business Overview
Table 193. Inflammatix Covid-19 Diagnostic Product
Table 194. Inflammatix Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 195. Inflammatix Recent Development
Table 196. Invetech Company Details
Table 197. Invetech Business Overview
Table 198. Invetech Covid-19 Diagnostic Product
Table 199. Invetech Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 200. Invetech Recent Development
Table 201. Janssen Diagnostics Company Details
Table 202. Janssen Diagnostics Business Overview
Table 203. Janssen Diagnostics Covid-19 Diagnostic Product
Table 204. Janssen Diagnostics Revenue in Covid-19 Diagnostic Business (2016-2021) & (US$ Million)
Table 205. Janssen Diagnostics Recent Development
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Immunoassay Features
Figure 3. Genomic and WGS Role Features
Figure 4. rRT-PCR Features
Figure 5. Global Covid-19 Diagnostic Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Laboratory Case Studies
Figure 8. Covid-19 Diagnostic Report Years Considered
Figure 9. Global Covid-19 Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Covid-19 Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Covid-19 Diagnostic Market Share by Regions: 2020 VS 2027
Figure 12. Global Covid-19 Diagnostic Market Share by Regions (2022-2027)
Figure 13. Global Covid-19 Diagnostic Market Share by Players in 2020
Figure 14. Global Top Covid-19 Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Diagnostic as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Covid-19 Diagnostic Revenue in 2020
Figure 16. Global Covid-19 Diagnostic Revenue Market Share by Type (2016-2021)
Figure 17. Global Covid-19 Diagnostic Revenue Market Share by Type (2022-2027)
Figure 18. North America Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Covid-19 Diagnostic Market Share by Type (2016-2027)
Figure 20. North America Covid-19 Diagnostic Market Share by Application (2016-2027)
Figure 21. North America Covid-19 Diagnostic Market Share by Country (2016-2027)
Figure 22. United States Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Covid-19 Diagnostic Market Share by Type (2016-2027)
Figure 26. Europe Covid-19 Diagnostic Market Share by Application (2016-2027)
Figure 27. Europe Covid-19 Diagnostic Market Share by Country (2016-2027)
Figure 28. Germany Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Covid-19 Diagnostic Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Covid-19 Diagnostic Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Covid-19 Diagnostic Market Share by Region (2016-2027)
Figure 38. China Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Covid-19 Diagnostic Market Share by Type (2016-2027)
Figure 46. Latin America Covid-19 Diagnostic Market Share by Application (2016-2027)
Figure 47. Latin America Covid-19 Diagnostic Market Share by Country (2016-2027)
Figure 48. Mexico Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Covid-19 Diagnostic Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Covid-19 Diagnostic Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Covid-19 Diagnostic Market Share by Country (2016-2027)
Figure 54. Turkey Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Covid-19 Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 58. Accelerate Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 59. Ador Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 60. Akkoni Biosystems Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 61. Alveo Technologies Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 62. Applied BioCode Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 63. Aus Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 64. BD Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 65. Biocartis Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 66. BioFire Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 67. bioMérieux Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 68. Bio-Rad Laboratories Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 69. Bosch Healthcare Solutions GmbH Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 70. Cepheid Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 71. Co-Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 72. Cue Health Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 73. Curetis Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 74. Diagenode Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 75. Diascopic Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 76. Diasorin Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 77. Expedeon Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 78. Fusion Genomics. Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 79. GenePOC Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 80. GenMark Dx Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 81. Hologic Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 82. Immunexpress Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 83. Inflammatix Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 84. Invetech Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 85. Janssen Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2016-2021)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

---